113 related articles for article (PubMed ID: 5468889)
1. The effect of prifinium bromide (1,1-diethyl-3-(diphenylmethylene)-2-methylpyrrolidium bromide) on the gastric antral motility in man.
Kihara T; Ishihara Y; Ota A
Arzneimittelforschung; 1970 Jun; 20(6):762-7. PubMed ID: 5468889
[No Abstract] [Full Text] [Related]
2. Studies on the ratio of equipotent oral and subcutaneous doses in man of prifinium bromide, a new synthetic spasmolytic.
Kumada S; Kozatani J; Seki M
Arzneimittelforschung; 1970 Feb; 20(2):237-40. PubMed ID: 5467469
[No Abstract] [Full Text] [Related]
3. [Inhibition of gastric motility by rectal administration of hyoscine-N-butylbromide].
Schmid E; Wagner T; Ritter U
Arzneimittelforschung; 1971 Jun; 21(6):813-5. PubMed ID: 5109265
[No Abstract] [Full Text] [Related]
4. Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog.
Sasaki D; Kido A; Yoshida Y
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):333-7. PubMed ID: 6147311
[TBL] [Abstract][Full Text] [Related]
5. Distribution, excretion and metabolism of prifinium bromide.
Nakai T; Noguchi H; Okui M; Tada K
Arzneimittelforschung; 1970 Aug; 20(8):1112-9. PubMed ID: 5536514
[No Abstract] [Full Text] [Related]
6. Toxicological and teratological studies of 1,1-diethyl-2-methyl-3-diphenylmethylenepyrrolidinium bromide (prifinium bromide), a new atropine-like drug.
Kumada S; Watanabe N; Nakai T
Arzneimittelforschung; 1972 Apr; 22(4):706-10. PubMed ID: 5068251
[No Abstract] [Full Text] [Related]
7. [Testing of orally administered spasmolytics demonstrated by the effect of hyoscine-N-butylbromide on gastric motility].
Schmid E; Bleichert A; Uberla K; Ritter U; Fehlhaber E
Arzneimittelforschung; 1968 Nov; 18(11):1449-53. PubMed ID: 4885158
[No Abstract] [Full Text] [Related]
8. [Effects of the drug HSp-2986 on antral motility, pyloric opening and gastric distensibility. Study with the fibrogastrocamera].
Espejo Romero H; Castillo Rosales T
G E N; 1972; 27(1):1-12. PubMed ID: 4632023
[No Abstract] [Full Text] [Related]
9. Effect of antispasmodic drugs on the colonic motility. Part II: Clinical study in man.
Sasaki D; Kido A; Yoshida Y
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):338-41. PubMed ID: 6147312
[TBL] [Abstract][Full Text] [Related]
10. [Clinical use of prifinium bromide in the treatment of pain caused by hypertonia of smooth muscle].
Scalco GB; Guerrera C; Liboni A; Malin L
G Clin Med; 1978; 59(9-10):430-42. PubMed ID: 33098
[No Abstract] [Full Text] [Related]
11. [On the differences of effect of atropine, scopolamine and some of their quaternary derivatives after subcutaneous and enteral administration with special reference to scopolamine-n-butylbromide].
Bauer R; Gross E; Scarselli V; Stockhaus K; Wick H
Arzneimittelforschung; 1968 Sep; 18(9):1132-7. PubMed ID: 5755927
[No Abstract] [Full Text] [Related]
12. [Studies on the spasmolytic efficacy of prifinium bromide in gastrointestinal pathology].
Garcia Hidalgo E; Fernández Navarro MD; Arias Vallejo E
Rev Esp Enferm Apar Dig; 1972 May; 37(3):397-406. PubMed ID: 5031449
[No Abstract] [Full Text] [Related]
13. Tolerability of fentonium bromide in Indonesian volunteers.
Wilmana PF; Istiantoro J; Sinto A; Darmansjah I
Curr Med Res Opin; 1977; 5(3):284-8. PubMed ID: 162668
[No Abstract] [Full Text] [Related]
14. [Radiological studies on the effect of 1,1-diethyl-3-(diphenylmethylene)-2-methyl pyrrolidinium bromide (prifinium bromide) on gallbladder mobility].
Inoue H; Tabuchi S; Andachi H
Naika Hokan; 1969 Nov; 16(11):427-34. PubMed ID: 5391804
[No Abstract] [Full Text] [Related]
15. [Objectivation of the pharmacodynamic effect of a new parasympatholytic by means of hypotonic duodenography].
Vollgraf H
Arzneimittelforschung; 1969 Sep; 19(9):1550-2. PubMed ID: 5394530
[No Abstract] [Full Text] [Related]
16. [Clinico-instrumental study of the therapeutic action of a new parasymaptholytic].
Barbara L; Corinaldesi R; Macaluso G; Luchetta L; Ricci P; Casadio R; Miglioli M
Clin Ter; 1976 Dec; 79(6):523-47. PubMed ID: 12909
[No Abstract] [Full Text] [Related]
17. [Effect of rectally applied hyoscin-N-butylbromide on small intestine motility].
Schmid E; Ritter U
Arzneimittelforschung; 1972 Dec; 22(12):2149. PubMed ID: 4679187
[No Abstract] [Full Text] [Related]
18. [Inhibition of small intestine motility by orally administered hyoscine-N-butylbromide].
Schmid E; Bleichert A; Kitzing J; Ritter U
Arzneimittelforschung; 1969 Jun; 19(6):998-9. PubMed ID: 5820047
[No Abstract] [Full Text] [Related]
19. [Objectivization of the pharmacodynamic effect of a new parasympatholytic using gastric pressure readings and clinical experiments under double-blind conditions].
Catalano F; Monello S; Blasi A
Minerva Dietol Gastroenterol; 1977; 23(3):201-18. PubMed ID: 34810
[No Abstract] [Full Text] [Related]
20. Combined intramuscular administration of depot fluphenazine and benztropinemesylate in chronic schizophrenic patients.
Bucci L
Curr Ther Res Clin Exp; 1971 Aug; 13(8):545-8. PubMed ID: 4999204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
